Early Stage Alzheimer’s Treatment
FDA grants standard approval of Alzheimer’s drug, marking a new milestone for the disease that impacts millions of Americans. Trial data showed that the treatment slows the progression by 27% for patients in the earliest stages of Alzheimer’s. The U.S. Food and Drug Administration on Thursday granted traditional approval to the Alzheimer’s drug lecanemab, known by the […]
Early Stage Alzheimer’s Treatment Read More »